CNS Biomarkers

Biomarkers give point by point measures of anomalous changes in the brain, which can help in early observation of possible infection in individuals with exceptionally mild or unordinary side effects. Individuals with Alzheimer's illness and related dementias advance at diverse rates, and biomarkers may assist anticipate and screen their progression.

  • Neuroimaging Enrichment for CNS Disease
  • CNS Drug Development Using Biomarkers
  • Cerebro Spinal Fluid Biomarkers
  • Biomarker Challenges in Rare Diseases

Related Conference of CNS Biomarkers

August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada
September 26-27, 2024

7th Annual Congress on Emergency Medicine and Acute Care

Amsterdam, Netherlands
October 14-15, 2024

11th World Machine Learning and Deep learning Conference

Barcelona, Spain
October 31-01, 2024

8th International Conference on Internal Medicine

Amsterdam, Netherlands
November 22-23, 2024

4th International Conference on Medical Research and Development

Aix-en-Provence, France
November 25-26, 2024

10th World Congress on Anesthesia and Critical Care

Aix-en-Provence, France

CNS Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in